GlassScriptPhysician profile
Stefan J Mlot
NPI 1962726760
$3,181.10
in general payments reported to CMS, 2019-2025
20 companies · $820 in 2025
The $820 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $121 · 2021: $422 · 2022: $486 · 2023: $363 · 2024: $816 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,353.02 | 2021-2025 | Inspire |
| Glaxosmithkline, LLC. | $587.58 | 2019-2025 | Nucala |
| Optinose US, INC. | $414.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $253.08 | 2022-2025 | |
| Cochlear Americas | $76.93 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Acclarent, INC | $56.57 | 2019 | |
| Medtronic, INC. | $55.57 | 2024 | Signia |
| Genzyme Corporation | $54.62 | 2025 | |
| Aerin Medical INC. | $46.15 | 2022 | |
| Smith+Nephew, INC. | $42.08 | 2023-2025 | Coblation, Rapid Rhino, Tula |
| Regeneron Healthcare Solutions, INC. | $41.70 | 2020-2025 | Dupixent |
| Alk-Abello, INC | $33.90 | 2019-2020 | |
| Integra Lifesciences Corporation | $26.36 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Stryker Corporation | $23.63 | 2025 | Scopis Ent |
| Merck Sharp & Dohme LLC | $22.70 | 2025 | Keytruda |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.23 | 2020 | |
| Neurent Medical Limited | $20.08 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Takeda Pharmaceuticals U.S.A., INC. | $19.90 | 2022 | |
| Grifols USA, LLC | $16.05 | 2024 | Xembify |
| Medtronic USA, INC. | $15.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefan Mlot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.